Rubius Therapeutics, Inc. announced the appointment of Dannielle Appelhans as chief operating officer, effective August 9, 2021. Most recently, Ms. Appelhans served as senior vice president of technical operations and chief technical officer at Novartis Gene Therapies, where she oversaw late-stage development, clinical and commercial manufacturing, supply chain and all supporting operational functions for the gene therapy unit and AAV portfolio.